title: The influence of the renin angiotensin system on abnormal expression of nerve growth factor in the spontaneously hypertensive rat.
abstract: 1. The levels of the neurotrophic factor, nerve growth factor (NGF) in the mesenteric vascular bed of the spontaneously hypertensive rat (SHR) were greater than those in the corresponding vascular bed of normotensive Wistar-Kyoto rats (WKY). 2. Administration of angiotensin II (200 ng/kg per min, by minipump) for 2 weeks to juvenile WKY rats increased the levels of NGF in the mesenteric vasculature to those seen in untreated SHR. 3. Administration of the angiotensin II receptor antagonists losartan (30 mg/kg per day, p.o.) or PD144277 (10 mg/kg per day, p.o.) to juvenile SHR for 4 weeks reduced the levels of NGF such that they were indistinguishable from the values obtained for normotensive WKY rats. 4. The results confirm the elevated level of NGF in the mesenteric vasculature of the SHR and suggest that angiotensin II may play a role in regulating the abnormal concentrations of the protein in this tissue.
authors.affiliation: Department of Clinical and Experimental Pharmacology, University of Adelaide, South Australia.
authors.forename: S
authors.initials: S
authors.lastname: Jeffreson
authors.forename: R
authors.initials: R
authors.lastname: Rush
authors.forename: C
authors.initials: C
authors.lastname: Zettler
authors.forename: D B
authors.initials: DB
authors.lastname: Frewin
authors.forename: R J
authors.initials: RJ
authors.lastname: Head
mesh_terms: D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000008:administration & dosage / Q000494:pharmacology; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology; D007260:Infusion Pumps; D019808:Losartan; D008638:Mesenteric Arteries / Q000187:drug effects / Q000378:metabolism; D009414:Nerve Growth Factors / Q000096:biosynthesis*; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology*; D013777:Tetrazoles / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D009414:Nerve Growth Factors; D013777:Tetrazoles; D000804:Angiotensin II; D019808:Losartan